A retrospective study to determine cardiac function of patients with breast cancer receiving Chemotherapy regimens combined with trastuzumab and pertuzumab in routine clinical practice setting
Latest Information Update: 15 Jul 2021
Price :
$35 *
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab (Primary) ; Antineoplastics
- Indications Breast cancer
- Focus Adverse reactions
- 15 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology